Baseline characteristics
A total of 94 patients were included, with 47 patients in each group. Mean age was 48.94 ± 6.73 years in the OG and 49.25 ± 6.98 years in the CG; corresponding BMI values were 22.18 ± 1.86 kg/m2 and 22.26 ± 1.78 kg/m2. No significant between-group differences were observed in age, BMI, indication for hysterectomy, parity, menopausal status, hypertension, diabetes mellitus, or surgical duration (all P > 0.05), indicating no evident imbalance in the measured baseline characteristics (Table 1).
| Characteristic | Observation group (n = 47) | Control group (n = 47) | t/χ2 | P |
| Age, years | 48.94 ± 6.73 | 49.25 ± 6.98 | 0.219 | 0.827 |
| BMI, kg/m² | 22.18 ± 1.86 | 22.26 ± 1.78 | 0.213 | 0.832 |
| Indication for hysterectomy, n (%) | | | 0.055 | 0.973 |
| Uterine fibroids | 25 (53.2) | 24 (51.1) | | |
| Adenomyosis | 14 (29.8) | 15 (31.9) | | |
| Endometriosis | 8 (17.0) | 8 (17.0) | | |
| Parity, n (%) | | | 0.172 | 0.678 |
| 1 | 22 (46.8) | 20 (42.6) | | |
| ≥2 | 25 (53.2) | 27 (57.4) | | |
| Menopausal status, n (%) | | | 0.052 | 0.820 |
| Premenopausal | 34 (72.3) | 33 (70.2) | | |
| Postmenopausal | 13 (27.7) | 14 (29.8) | | |
| Hypertension, n (%) | 8 (17.0) | 9 (19.1) | 0.072 | 0.789 |
| Diabetes mellitus, n (%) | 4 (8.5) | 5 (10.6) | — | 1.000 |
| Surgical duration, min | 102.60 ± 18.40 | 104.30 ± 19.10 | 0.439 | 0.661 |
Table 1: Baseline demographic and clinical characteristics of the two groups. Continuous variables are presented as mean ± SD and categorical variables as n (%). BMI, body mass index. Fisher exact test was used for diabetes mellitus because of the small expected cell count.
Postoperative clinical indicators
Early postoperative clinical indicators differed between the two groups. Because oral intake and first flatus occurred before or around rehabilitation initiation, these findings were interpreted as descriptive between-group differences rather than effects attributable to the combined exercise program. Time to first flatus was 15.65 ± 2.11 h versus 23.65 ± 3.45 h (mean difference [MD], -8.00 h; 95% CI, -9.17 to -6.83; P < 0.001). Resumption of oral intake occurred at 6.15 ± 1.88 h versus 9.56 ± 2.89 h (MD, -3.41 h; 95% CI, -4.41 to -2.41; P < 0.001). Postoperative hospital stay was 3.18 ± 1.11 days versus 6.08 ± 1.89 days (MD, -2.90 days; 95% CI, -3.54 to -2.26; P < 0.001) (Figure 1).

Figure 1: Comparison of postoperative clinical recovery parameters between the two groups. Data are presented as mean ± SD. *P < 0.05. Please click here to view a larger version of this figure.
Pelvic floor symptoms
At baseline, no included patient had documented pelvic floor dysfunction symptoms because preexisting pelvic floor dysfunction was an exclusion criterion. At the 2-month follow-up, lower abdominal or pelvic discomfort occurred in 1/47 (2.1%) patients in the OG and 8/47 (17.0%) in the CG; urinary incontinence in 1/47 (2.1%) and 5/47 (10.6%); abnormal urination in 4/47 (8.5%) and 11/47 (23.4%); abnormal defecation in 2/47 (4.3%) and 10/47 (21.3%); and abnormal vaginal symptoms in 3/47 (6.4%) and 13/47 (27.7%), respectively. Overall, the OG showed lower frequencies of postoperative pelvic floor symptom indicators (Figure 2).

Figure 2: Comparison of pelvic floor symptom indicators between the two groups at the 2-month follow-up. Data are presented as number of patients (n). No included patient had documented pelvic floor dysfunction symptoms at baseline because preexisting pelvic floor dysfunction was an exclusion criterion. *P < 0.05. Please click here to view a larger version of this figure.
Pelvic floor muscle performance
Quantitative pelvic floor muscle performance grades were available at the 2-month follow-up. Sustained-contraction performance was 3.25 ± 0.33 in the OG and 2.71 ± 0.21 in the CG (MD, 0.54; 95% CI, 0.43-0.65; P < 0.001). Rapid-contraction performance was 2.08 ± 0.14 and 1.53 ± 0.11, respectively (MD, 0.55; 95% CI, 0.50-0.60; P < 0.001). Within the predefined 0-5 grading framework, these values correspond approximately to moderate versus weak-to-moderate sustained performance and weak versus very weak-to-weak rapid performance. Because no validated normal cutoff or minimal clinically important difference has been established for this device-specific scale in post-hysterectomy patients, the values should be interpreted descriptively rather than as evidence of normalization (Figure 3).

Figure 3: Comparison of pelvic floor muscle performance between the two groups. Data are presented as mean performance grade (0–5) ± SD. *P < 0.05. Please click here to view a larger version of this figure.
Early postoperative pain
Postoperative pain severity was assessed at 12 h and 24 h to characterize acute pain during immediate recovery. Repeated-measures analysis showed lower pain severity in the OG than in the CG across the two time points (P < 0.05). These findings represent descriptive between-group differences in acute postoperative pain; because the 12 h assessment could precede or overlap with rehabilitation initiation, they should not be interpreted as an analgesic effect attributable to the combined exercise program (Figure 4).

Figure 4: Distribution of acute postoperative pain severity at 12 and 24 h after surgery. Data are presented as number of patients (n). Please click here to view a larger version of this figure.
Quality of life
At the 2-month follow-up, the OG had a higher I-QOL score than the CG (79.58 ± 8.11 vs. 69.87 ± 8.71 points; MD, 9.71 points; 95% CI, 6.26-13.16; P < 0.001), indicating better incontinence-related quality of life. In contrast, the PFIQ-7 score was lower in the OG (36.89 ± 9.77 vs. 51.95 ± 11.89 points; MD, -15.06 points; 95% CI, -19.52 to -10.60; P < 0.001), indicating a lower negative impact of pelvic floor symptoms on daily life. Thus, the two instruments showed directionally consistent results (Figure 5).

Figure 5: Comparison of quality-of-life scores between the two groups. Data are presented as mean score (points) ± SD. *P < 0.05. Please click here to view a larger version of this figure.
Supplementary Figure 1: Participant-flow diagram. This shows the number of records screened, excluded (with reasons), and finally included in the observation group and control group. Please click here to download this file.
Supplementary File 1: De-identified dataset used for the statistical analyses. Please click here to download this file.